Results 191 to 200 of about 47,434 (363)

USP44, ZNF454, and GPRC5B ctDNA Methylation Markers in Breast Cancer: Limited Clinical Relevance for Disease Monitoring and Tumor Characteristics

Asia-Pacific Journal of Clinical Oncology, EarlyView.
We selected breast cancer‐specific DNA methylation markers using The Cancer Genome Atlas (TCGA). We analyzed the methylation and expression patterns of candidate genes in breast cancer cell lines, ctDNA, and tissue samples. The relationship between ctDNA methylation markers and the clinicopathological features of breast cancer patients was investigated.
Young Ju Jeong, Chang‐Ho Jeon, Hoon Kyu Oh, Jeong Kyu Kim, Chun‐Seok Yang, Na‐Rang Lee, Doyeon Kim   +6 more
wiley   +1 more source

El papel de la enfermería en la Biopsia Líquida [PDF]

, 2019
Introducción: El cáncer sigue constituyendo una de las principales causas de morbilidad del mundo. Las estimaciones poblacionales indican que el número de casos probablemente aumente a un 70% en las próximas décadas. Desde el año 2000 en nuestro país, el
Villaverde Hueso, María
core  

The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines [PDF]

, 2017
Alessandro Perez, Anna Barbara Di Stefano, Marta Castiglia, Marisa Sorrentino, Domenica Matranga, Frank N. Grisafi, Cláudia Rita Corso, Gian Luca Scoarughi, Gaetano Barbato, Nadia Barraco, Valentina Calò, F. Di Piazza, Daniela Massihnia, Angela Listì, Luisa Castellana, Attilio Guarini, Lavinia Insalaco, Enrico Bronte, Antonio Russo   +18 more
openalex   +1 more source

Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma

Nature Network Boston
Circulating tumor DNA (ctDNA) detection can predict clinical risk in early-stage tumors. However, clinical applications are constrained by the sensitivity of clinically validated ctDNA detection approaches.
James R. M. Black, G. Bartha, Charles W. Abbott, S. Boyle, Takahiro Karasaki, Bailiang Li, Rui Chen, Jason Harris, S. Veeriah, Martina Colopi, Maise Al Bakir, W. K. Liu, J. Lyle, F. Navarro, Josette M. Northcott, R. Pyke, M. Hill, K. Thol, A. Huebner, Chris Bailey, Emma C Colliver, Carlos Martínez-Ruiz, Kristiana Grigoriadis, Piotr Pawlik, David A Moore, Daniele Marinelli, Oliver G Shutkever, Cian Murphy, Monica Sivakumar, J. Shaw, A. Hackshaw, N. Mcgranahan, M. Jamal-Hanjani, A. Frankell, Richard O Chen, C. Swanton   +35 more
semanticscholar   +1 more source

Circulating tumour DNA as a predictor of survival of patients with diffuse large B‐cell lymphoma in a daily practice

British Journal of Haematology, EarlyView.
Circulating tumour DNA (ctDNA) is a promising biomarker for diffuse large B‐cell lymphoma (DLBCL) risk stratification and treatment response assessment, but real‐world studies were limited. Using a targeted sequencing approach (521‐gene panel), we showed that (1) baseline ctDNA level correlated with tumour burden and was an independent predictor of ...
Prokop Vodicka, Iva Hamova, Adriana Velasova, Kristyna Kupcova, Petra Zemankova, Petr Nehasil, Anton Tkachenko, Katerina Lochovska, Sarka Muzikova, Sarka Hrabetova, Jitka Dlouha, Petra Blahovcova, Tomas Frouz, Jana Senavova, Lucie Dlouha, Kamila Polgarova, Magdalena Klanova, Jana Salkova, Katerina Benesova, Pavel Klener, Marek Trneny, Ondrej Havranek   +21 more
wiley   +1 more source

Genomic profiling for advanced non-small-cell lung cancer (NSCLC) from circulating tumour DNA (ctDNA) [PDF]

, 2017
Herbert H. Loong, Victoria M. Raymond, Daniel T. T. Chua, P. Teo, T. Yung, Richard B. Lanman, Stan Skrzypczak, Tony Mok   +7 more
openalex   +1 more source

DNA Methylation in Ovarian and Endometrial Cancers: Predictive and Mechanistic Roles in PARP Inhibitor and ICI Response

Cancer Science, EarlyView.
Cancer treatment is shifting from an organ‐based framework to one driven by biological phenotypes, and DNA methylation is increasingly recognized as an important factor that governs tumor behavior beyond genetic mutations. In gynecologic cancers, BRCA1 and MLH1 promoter methylation–associated homologous recombination deficiency and mismatch repair ...
Shuhei Kitamura, Ayumi Taguchi, Kana Tamai, Yoko Yamamoto, Anh Quynh Duong, Daisuke Yoshimoto, Ayako Mori, Aya Ishizaka, Saki Tsuchimochi, Kenbun Sone, Masahito Kawazu, Katsutoshi Oda, Yasushi Hirota   +12 more
wiley   +1 more source

Plasma EGFR mutation ctDNA dynamics in patients with advanced EGFR-mutated NSCLC treated with Icotinib: phase 2 multicenter trial result

Scientific Reports
Plasma epidermal growth factor receptor mutation (EGFRm) circulating tumor DNA (ctDNA) dynamics exhibit promise in predicting outcomes in patients with EGFRm-advanced non-small cell lung cancer (NSCLC).
Yaping Hong, Wu Zhuang, Jinhuo Lai, Haipeng Xu, Yueming He, Jinlan Lin, Qin Shi, Shengjia Chen, Zhangzhou Huang, Shijie Chen, Dongzhu Lu, Gen Lin, Yunjian Huang   +12 more
doaj   +1 more source

Studies on the origin of crop species by restriction endonuclease analysis of organellar DNA. II. Restriction analysis of ctDNA of 11 Prunus species.

, 1986
T. Kaneko, Toru Terachi, Koichiro Tsunewaki   +2 more
openalex   +2 more sources

Systemic Surveillance Guidelines for Uveal Melanoma: A Systematic Review

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background Uveal melanoma (UM) is the most common primary intraocular tumour. Despite effective local therapies, UM has a high risk of metastatic recurrence, most frequently to the liver. A significant proportion of patients treated definitively for primary UM eventually experience metastatic disease. Systemic surveillance to detect recurrence
Farzana Y. Zaman, Aisha Ghaus, Mark Shackleton, Damien Kee, Anthony M. Joshua, Roderick O'Day, Malaka Ameratunga   +6 more
wiley   +1 more source